<Disease><Name>CEROID LIPOFUSCINOSIS, NEURONAL, 11</Name><Synonym>CLN11;</Synonym><OMIM><Number>614706</Number><URL>http://omim.org/entry/614706</URL></OMIM><Orphanet><Number>314629</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=314629</URL></Orphanet><Protein><Number>Granulins</Number><URL>http://www.uniprot.org/uniprot/P28799</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>17q21.31</Gene><ICD>E75.4</ICD><Summary>rare;autosomal recessive;mutation in the GRN gene</Summary><Symptoms><symtomp><id>3424</id><symptom>abnormal movement</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1942</id><symptom>ataxia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2211</id><symptom>blindness, visual loss, visual impairment</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1966</id><symptom>cerebellar atrophy or hypoplasia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2160</id><symptom>EEG abnormalities [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2336</id><symptom>Electron microscopy [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2213</id><symptom>MRI, brain, abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1915</id><symptom>onset, adulthood / adoulthood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3817</id><symptom>retinal dystrophy</symptom><category>EYES</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites /><Literatures><literature><id>5001</id><title>Human NCL Neuropathology</title><author>Radke J,</author><journal>Biochim Biophys Acta</journal><year>2015</year><book /><volume>1852</volume><number>10</number><pages>2262-2266</pages><co_aut>Stenzel W, Goebel HH</co_aut></literature><literature><id>5013</id><title>Recurrent generalized seizures, visual loss, and palinopsia as phenotypic features of neuronal ceroid lipofuscinosis due to pro</title><author>Canafoglia L,</author><journal>Epilepsia. 2014 Jun;55(6):e56-9. d</journal><year>2014</year><book /><volume>55</volume><number>6</number><pages>e56-59</pages><co_aut>et al.</co_aut></literature><literature><id>5014</id><title>Progressive retinal degeneration and accumulation of autofluorescent lipopigments in Progranulin deficient mice</title><author>Hafler BP,</author><journal>Brain Res</journal><year>2014</year><book /><volume>1588</volume><number>0</number><pages>168-174</pages><co_aut>et al.</co_aut></literature><literature><id>5002</id><title>Neuronal Ceroid-Lipofuscinoses</title><author>Mole SE,</author><journal>Source  GeneReviews&#174; [Internet]</journal><year>2013</year><book /><volume>0</volume><number>0</number><pages /><co_aut>Williams RE</co_aut></literature><literature><id>5012</id><title>Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage</title><author>Smith KR,</author><journal>Am J Hum Genet</journal><year>2012</year><book /><volume>90</volume><number>6</number><pages>1102-1107</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>